https://doi.org/10.4081/aiua.2025.13867
Predictors of treatment failure and outcome assessment of extracorporeal shock wave lithotripsy with the Dornier Compact Delta® III Pro: experience from the first 1000 treatments
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Published: 10 June 2025
Background: The Dornier Compact Delta® III Pro is a next-generation extracorporeal shock wave lithotripter featuring flat-panel detector technology for enhanced imaging and a compact modular design. This study evaluates treatment outcomes and predictors of failure for this system, representing the first published clinical experience.
Methods: We retrospectively analyzed the first 1,000 consecutive patients treated with the Dornier Compact Delta® III Pro for renal or ureteric stones between May 2022 and November 2023 at a secondary hospital. Stone-free status was assessed via radiography, ultrasonography, or computed tomography (CT) within three months post-treatment. Predictive factors for treatment failure were identified through univariate and multivariate logistic regression analyses.
Results: The cohort had a median age of 37 years (IQR: 32- 44.2) and a body mass index (BMI) of 26 kg/m² (IQR: 24-29). Key characteristics included: prior urologic interventions in 36.6% of patients, single stones in 79.8% (median size 9 mm, IQR: 7-10), a median stone density of 1000 Hounsfield Units (HU) (IQR: 760-1200), and hydronephrosis observed in 55.3% of cases. Initial ESWL success was achieved in 80.5% of cases, increasing to 87.5% following repeat sessions (mean treatments: 1.2). Multivariate analysis identified four independent predictors of treatment failure: prior urologic intervention (adjusted odds ratio [aOR] 2.64, 95% CI 1.75-4.00, p<0.001), multiple stones (aOR 0.45, 95% CI 0.24-0.77, p = 0.011), increased skin-to-stone distance (per cm: aOR 1.18, 95% CI 1.06-1.30, p<0.001), and higher stone density (per 100 HU: aOR 1.12, 95% CI 1.06-1.18, p<0.001).
Conclusions: The Dornier Compact Delta® III Pro achieved an 87.3% stone-free rate with failure predictors consistent with established lithotripsy literature. These findings support the adoption of this device as an effective ESWL system, particularly for institutions prioritizing advanced imaging and a space-efficient design.
Downloads
Stamatelou K, Goldfarb DS. Epidemiology of kidney stones. Healthcare (Basel) 2023;11:424. DOI: https://doi.org/10.3390/healthcare11030424
Sarier M, Duman I, Callioglu M, et al. Outcomes of conservative management of asymptomatic live donor kidney stones. Urology 2018; 118:43-46. DOI: https://doi.org/10.1016/j.urology.2018.04.035
Mosquera Seoane L, Ortiz Salvador JB, Budia Alba A, Perez Fentes DA. Technological innovations in shock wave lithotripsy. Actas Urol Esp (Engl Ed) 2024; 48:105-10. DOI: https://doi.org/10.1016/j.acuroe.2023.09.001
Dornier MedTech. Dornier Delta III. Secondary Dornier MedTech. Dornier Delta III 2023. https://www.dornier.com/products-item/dornier-delta-iii/
Lee SM, Collin N, Wiseman H, Philip J. Optimisation of shock wave lithotripsy: a systematic review of technical aspects to improve outcomes. Transl Androl Urol 2019;8:s389-s97. DOI: https://doi.org/10.21037/tau.2019.06.07
Wagenius M, Oddason K, Utter M, et al. Factors influencing stone-free rate of Extracorporeal Shock Wave Lithotripsy (ESWL); a cohort study. Scand J Urol. 2022;56:237-43. DOI: https://doi.org/10.1080/21681805.2022.2055137
Shinde S, Al Balushi Y, Hossny M, et al. Factors affecting the outcome of extracorporeal shockwave lithotripsy in urinary stone treatment. Oman Med J. 2018; 33:209-17. DOI: https://doi.org/10.5001/omj.2018.39
Neisius A, Wöllner J, Thomas C, et al. Treatment efficacy and outcomes using a third generation shockwave lithotripter. BJU Int 2013; 112:972-81. DOI: https://doi.org/10.1111/bju.12159
Campbell MF, Walsh PC, Wein AJ, et al. Campbell-Walsh-Wein urology. 12th ed. editors, Roger R. Dmochowski, Louis R. Kavoussi, Craig A. Peters ed: Elsevier, 2021.
Al-Zubi M, Al Sleibi A, Elayan BM, et al. The effect of stone and patient characteristics in predicting extra-corporal shock wave lithotripsy success rate: A cross sectional study. Ann Med Surg 2021;70:102829. DOI: https://doi.org/10.1016/j.amsu.2021.102829
Fisang C, Anding R, Müller SC, et al. Urolithiasis--an interdisciplinary diagnostic, therapeutic and secondary preventive challenge. Dtsch Arztebl Int. 2015; 112:83-91. DOI: https://doi.org/10.3238/arztebl.2015.0083
Gültekin MH, Türegün FA, Ozkan B, et al. Does previous open renal stone surgery affect the outcome of extracorporeal shockwave lithotripsy treatment in adults with renal stones? J Endourol 2017; 31:1295-300. DOI: https://doi.org/10.1089/end.2017.0473
Abdel-Khalek M, Sheir KZ, Mokhtar AA, et al. Prediction of success rate after extracorporeal shock-wave lithotripsy of renal stones--a multivariate analysis model. Scand J Urol Nephrol 2004;38:161-7. DOI: https://doi.org/10.1080/00365590310022626
El-Nahas AR, El-Assmy AM, Mansour O, Sheir KZ. A prospective multivariate analysis of factors predicting stone disintegration by extracorporeal shock wave lithotripsy: the value of high-resolution noncontrast computed tomography. Eur Urol 2007; 51:1688-93. DOI: https://doi.org/10.1016/j.eururo.2006.11.048
Alharbi AS, Gameraddin M, Gareeballah A, et al. Assessment of Hounsfield units and factors associated with fragmentation of renal stones by extracorporeal shock wave lithotripsy: a computerized tomography study. Tomography 2024; 10:90-100. DOI: https://doi.org/10.3390/tomography10010008
Abou-Farha M, El-Abd A, Gameel T, et al. Efficacy of extracorporeal shockwave lithotripsy, with modified position of the machine head in the treatment of lower calyceal stones in obese patients. Urol Ann 2022; 14:81-84. DOI: https://doi.org/10.4103/UA.UA_176_20
Garg M, Johnson H, Lee SM, et al. Role of Hounsfield unit in predicting outcomes of shock wave lithotripsy for renal calculi: outcomes of a systematic review. Curr Urol Rep 2023;24:173-85. DOI: https://doi.org/10.1007/s11934-023-01145-w
Abdelaziz H, Elabiad Y, Aderrouj I, et al. The usefulness of stone density and patient stoutness in predicting extracorporeal shock wave efficiency: Results in a North African ethnic group. Can Urol Assoc J. 2014; 8:E567-9. DOI: https://doi.org/10.5489/cuaj.1849
Elkoushy MA, Hassan JA, Morehouse DD, et al. Factors determining stone-free rate in shock wave lithotripsy using standard focus of Storz Modulith SLX-F2 lithotripter. Urology 2011;78:759-63. DOI: https://doi.org/10.1016/j.urology.2011.03.005
Suzuki K, Yamashita Y, Yoshida M, Matuzaki J. A single center experience with a lithotripsy machine "Modulith SLX-F2" : evaluation of dual focus system and clinical results. Hinyokika Kiyo 2010;56:81-6.
Lv JL. A new optical coupling control technique and application in SWL. Urolithiasis 2016; 44:539-44. DOI: https://doi.org/10.1007/s00240-016-0874-9
Lee CH, Koh SK, Kim HJ. Experience of extracorporeal shock wave lithotripsy with electroconductive lithotriptor (ECL, EDAPSonolith Praktis) in 703 patients with urinary calculi. Korean J Urol 2005; 46:375-81.
Sheir KZ, Madbouly K, Elsobky E. Prospective randomized comparative study of the effectiveness and safety of electrohydraulic and electromagnetic extracorporeal shock wave lithotriptors. J Urol 2003;170:389-92. DOI: https://doi.org/10.1097/01.ju.0000075080.58359.46
Kim YH, Kim HJ, Oh JS. Comparative study of the results of electromagnetic (EML Dornier Compact Delta®) and electroconductive (ECL, EDAP-Sonolith Praktis) extracorporeal shock wave lithotriptors. Korean J Urol 2007; 48:1027-34. DOI: https://doi.org/10.4111/kju.2007.48.10.1027
How to Cite
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
PAGEPress has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.